Katrina Thornber, Author at European Medical Journal - Page 36 of 50

Boron Neutron Capture Enhanced Proton Therapy Shows Increased Cell Killing Effect

A new study reveals that combining proton beam therapy with boron neutron capture reactions increases its cell-killing effect, with higher boron concentrations yielding stronger therapeutic results…

Oral Microbiome Linked to Mental Health During Pregnancy

Emerging research highlights the oral microbiome’s potential role in maternal mental health, suggesting an oral-brain-behaviour axis distinct from the gut-brain axis.

New Data Challenge Traditional Gastroparesis Diagnostics

Gastroparesis diagnoses based solely on gastric emptying studies may overlook broader gastrointestinal dysmotility, necessitating a shift in diagnostic approaches.

Increased Cardiovascular Risks for Patients with Vitiligo

Conditions such as cerebral infarction, acute myocardial infarction, pulmonary embolism, and venous thrombosis were more prevalent among those with vitiligo.

Breakthrough Neuron-Wrapping Devices Could Transform Neurological Treatments

A new wireless device that wraps around neurons may transform treatment for neurological disorders, aiding neuron function by acting as synthetic myelin.

Percutaneous Aspiration Offers Hope for Patients with Right-Sided Infective Endocarditis

The CLEAR-IE study highlights the clinical effectiveness of percutaneous mechanical aspiration in treating right-sided infective endocarditis resistant to medical therapy.

Blood Flow Restriction Therapy Boosts Knee Osteoarthritis Recovery

Blood flow restriction therapy shows greater pain and strength improvements in knee osteoarthritis, study finds.

Cardiovascular Disease in Pregnancy Tied to Higher Mortality Rates

Pregnant patients with cardiovascular disease face a significantly increased risk of severe maternal morbidity and mortality, according to a large US-based study.

New Approach Offers Hope for Drug-Resistant Lung Cancer

Researchers have developed a novel treatment for non-small cell lung cancer (NSCLC) that uses customised antisense oligonucleotides (ASOs) to selectively target drug-resistant EGFR mutations.

Early RSV Vaccination in Pregnancy Enhances Neonatal Protection

he study aimed to evaluate how gestational age at the time of vaccination and the time elapsed until delivery impacted antibody levels in the newborn.